Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Minority Interest (2016 - 2017)

Historic Minority Interest for Pharma (IGC) over the last 9 years, with Q4 2017 value amounting to -$9007.0.

  • Pharma's Minority Interest fell 7.78% to -$9007.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$9007.0, marking a year-over-year decrease of 7.78%. This contributed to the annual value of -$8836.0 for FY2017, which is 10187.18% down from last year.
  • According to the latest figures from Q4 2017, Pharma's Minority Interest is -$9007.0, which was down 7.78% from -$8854.0 recorded in Q3 2017.
  • In the past 5 years, Pharma's Minority Interest registered a high of $576803.0 during Q2 2014, and its lowest value of -$9007.0 during Q4 2017.
  • Moreover, its 5-year median value for Minority Interest was $523033.0 (2014), whereas its average is $393083.6.
  • Per our database at Business Quant, Pharma's Minority Interest surged by 695.94% in 2014 and then crashed by 10210.49% in 2017.
  • Pharma's Minority Interest (Quarter) stood at $531772.0 in 2013, then increased by 4.67% to $556612.0 in 2014, then grew by 2.35% to $569702.0 in 2015, then tumbled by 101.58% to -$9000.0 in 2016, then decreased by 0.08% to -$9007.0 in 2017.
  • Its last three reported values are -$9007.0 in Q4 2017, -$8854.0 for Q3 2017, and -$8790.0 during Q2 2017.